VERNON HILLS, Ill.--(BUSINESS WIRE)--Applied NeuroSolutions, Inc. (OTC BB:APNS)(www.AppliedNeuroSolutions.com), a Company focused on the development of an integrated product portfolio for the treatment and diagnosis of Alzheimer’s disease (“AD”), recently announced its financial results for the quarter ended September 30, 2008 and today provides an update on its serum diagnostic development program.
